ความชุกของเชื้อแบคทีเรียฉวยโอกาสที่แยกได้จากสิ่งส่งตรวจของผู้ป่วยที่เข้ารับการรักษาในโรงพยาบาลร้อยเอ็ด ปี พ. ศ. 2560
คำสำคัญ:
ความชุก; เชื้อฉวยโอกาส; สิ่งส่งตรวจบทคัดย่อ
หลักการและวัตถุประสงค์: โรคติดเชื้อแบคทีเรียฉวยโอกาสในโรงพยาบาลเป็นปัญหาสำคัญทางการแพทย์และสาธารณสุขในประเทศต่างๆทั่วโลก อีกทั้งในปัจจุบันปัญหาการเกิดการดื้อยาต้านจุลชีพในผู้ป่วยที่เข้ารับการรักษาในโรงพยาบาลมีแนวโน้มเพิ่มสูงขึ้นวัตถุประสงค์ของการวิจัย เพื่อศึกษาความชุกของเชื้อแบคทีเรียฉวยโอกาสที่แยกได้จากสิ่งส่งตรวจของผู้ป่วยที่เข้ารับการรักษาในโรงพยาบาล
วิธีการศึกษา: รูปแบบการศึกษาครั้งนี้เป็นการศึกษาเชิงพรรณนาโดยดำเนินการเก็บรวบรวมข้อมูลผลการตรวจเพาะเชื้อในระบบทางเดินหายใจ ระบบทางเดินปัสสาวะและระบบไหลเวียนโลหิต จากเวชระเบียนผู้ป่วยและข้อมูลจากห้องปฏิบัติการจุลชีวิทยาคลินิก โรงพยาบาลร้อยเอ็ด ระหว่างวันที่ 1 มกราคม 2560 ถึงวันที่ 31 ธันวาคม 2560 ใช้สถิติเชิงพรรณนาในการวิเคราะห์ข้อมูล
ผลการศึกษา:ระหว่างวันที่ 1 มกราคม 2560 ถึงวันที่ 31 ธันวาคม 2560 มีเชื้อแบคทีเรียที่แยกได้จากผู้ป่วยที่เข้ารับการรักษาในโรงพยาบาลร้อยเอ็ด ทั้งหมด 15, 367 isolation เชื้อที่พบบ่อยได้แก่ E. coli ร้อยละ 16.31 A.baumannii ร้อยละ 15.10 K. pneumoniae ร้อยละ 13.45 และ P. aeruginosa ร้อยละ 11.22 โดยแยกได้จากระบบทางเดินหายใจ 5,968 isolates มีเชื้อที่พบบ่อยได้แก่ A.baumannii ร้อยละ 27.58 K. pneumoniae ร้อยละ 21.26 P. aeruginosa ร้อยละ 20.69 และ E. coli ร้อยละ 5.53 ระบบทางเดินปัสสาวะ 3,266 isolates มีเชื้อที่พบบ่อยได้แก่ E. coli ร้อยละ 34.91 Enterococcus spp.ร้อยละ 29.52 K. pneumonia ร้อยละ 10.47 และ P. aeruginosa ร้อยละ 6.12 และระบบไหลเวียนโลหิต 4,082 isolates มีเชื้อที่พบบ่อยได้แก่ Coagulase Negative Staphylococci ร้อยละ 27.14 E. coli ร้อยละ 14.80 B. pseudomallei ร้อยละ 8.79 Staphylococcus aureus ร้อยละ 8.21
สรุป: จากผลการตรวจเพาะเชื้อจากสิ่งส่งตรวจของผู้ป่วยพบเชื้อแบคทีเรียทั้งหมด 15, 367 isolation เชื้อที่พบได้บ่อยที่สุดคือ E.coli, A.baumannii, K.pneumoniae และ P. aeruginosa ระบบทางเดินหายใจและระบบทางเดินปัสสาวะเชื้อที่พบบ่อยคือ A.baumannii, K. pneumoniae, P. aeruginosa, E. coli ส่วนระบบไหลเวียนโลหิตเชื้อที่พบบ่อยคือ Coagulase Negative Staphylococci, E. coli, B. pseudomallei และ Staphylococcus aureus
เอกสารอ้างอิง
1. Pollack A. Doctors Struggle to Treat Gram-Negative Bacterial Infections. The New York Times [Internet]. 2010 Feb 26 [cited May 18, 2018]; Available from: https://www.nytimes.com/2010/02/27/business/27germ.html
2. Lizioli A, Privitera G, Alliata E, Antonietta Banfi EM, Boselli L, Panceri ML, et al. Prevalence of nosocomial infections in Italy: result from the Lombardy survey in 2000. J Hosp Infect 2003; 54: 141–8.
3. Pancharti P, Leksawas N, Sukamwang K, Tantisiriwat W, Danchaivijitr S. Impacts of nosocomial infection among elderly patients in Inburi Hospital. J Med Assoc Thai 2005; 88: S83-85.
4. Nosocomiale infecties in België, deel 2: impact op Mortaliteit en Kosten [Internet]. [cited May 18, 2018]. Available from: /en/node/792
5. Rosenthal VD, Maki DG, Jamulitrat S, Medeiros EA, Todi SK, Gomez DY, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control 2010; 38: 95-104.e2.
6. Danchaivijitr S, Dhiraputra C, Santiprasitkul S, Judaeng T. Prevalence and impacts of nosocomial infection in Thailand 2001. J Med Assoc Thai 2005; 88: S1–9.
7. Danchaivijitr S, Judaeng T, Sripalakij S, Naksawas K, Plipat T. Prevalence of nosocomial infection in Thailand 2006. J-Med Assoc Thai 2007; 90: 1524.
8. Dejsirilert S, Suankratay C, Trakulsomboon S, Thongmali O, Sawanpanyalert P, Aswapokee N, et al. National Antimicrobial Resistance Surveillance, Thailand (NARST) data among clinical isolates of Pseudomonas aeruginosa in Thailand from 2000 to 2005. J Med Assoc Thai 2009; 92: S68-75.
9. Petdachai W. Ventilator-associated pneumonia in a newborn intensive care unit. Southeast Asian J Trop Med Public Health 2004; 35: 724–9.
10. Bayani M, Siadati S, Rajabnia R, Taher AA. Drug Resistance of Pseudomonas aeruginosa and Enterobacter cloacae Isolated from ICU, Babol, Northern Iran. Int J Mol Cell Med 2013; 2: 204–9.
11. Gurung J, Khyriem AB, Banik A, Lyngdoh WV, Choudhury B, Bhattacharyya P. Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit. Indian J Crit Care Med 2013; 17: 214–8.
12. Rhodes D, Cheng AC, McLellan S, Guerra P, Karanfilovska D, Aitchison S, et al. Reducing Staphylococcus aureus bloodstream infections associated with peripheral intravenous cannulae: successful implementation of a care bundle at a large Australian health service. J Hosp Infect 2016; 94: 86-91
13. Nuvials X, Palomar M, Alvarez-Lerma F, Olaechea P, Otero S, Uriona S, et al. Primary bacteriemia and catheter related bloodstream infection in patients admitted to ICU. risk factors associated with mortality. ENVIN-HELICS registry data. Intensive Care Med Exp 2015; 3: A889.
14. Sader HS, Castanheira M, Flamm RK, Mendes RE, Farrell DJ, Jones RN. Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia. Int J Antimicrob Agents 2015; 46: 53–9.
15. Tumbarello M, De Pascale G, Trecarichi EM, Spanu T, Antonicelli F, Maviglia R, et al. Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients. Intensive Care Med 2013; 39: 682–92.
16. Nathwani D, Raman G, Sulham K, Gavaghan M, Menon V. Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control 2014; 3: 32.
17. Djordjevi Z, Gajovi O, Mijailovi Z, Ili A, Stoli R. [Risk factors of nosocomial infections caused by piperacillin-tazobactam resistant Pseudomonas aeruginosa]. Srp Arh Celok Lek 2013; 141: 640–7.
18. Ryakitimbo A, Philemon R, Mazuguni F, Msuya L. Prevalence and antimicrobial sensitivity pattern of urinary tract infection among children with cerebral palsy, Moshi, Tanzania. Pediatr Health Med Ther 2018; 9: 59–65.
19. Anígilájé EA, Bitto TT. Prevalence and Predictors of Urinary Tract Infections among Children with Cerebral Palsy in Makurdi, Nigeria. Int J Nephrol 2013; 2013: 937268.
20. Lin S-H, Kuo P-H, Hsueh P-R, Yang P-C, Kuo S-H. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa. Respirol Carlton Vic 2007; 12: 81–7.
21. El-Sheikh SM, El-Assouli SM, Mohammed KA, Albar M. Bacteria and viruses that cause respiratory tract infections during the pilgrimage (Haj) season in Makkah, Saudi Arabia. Trop Med Int Health TM IH 1998; 3: 205–9.
22. Alamoudi OS. Bacterial infection and risk factors in outpatients with acute exacerbation of chronic obstructive pulmonary disease: a 2-year prospective study. Respirol Carlton Vic 2007; 12: 283–7.
23. Lewnard JA, Givon-Lavi N, Huppert A, Pettigrew MM, Regev-Yochay G, Dagan R, et al. Epidemiological Markers for Interactions Among Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Upper Respiratory Tract Carriage. J Infect Dis 2016 15;213:1596–605.
24. Numazaki K, Chiba S, Umetsu M, Tanaka T, Yoshimura H, Kuniya Y, et al. Etiological agents of lower respiratory tract infections in Japanese children. Vivo Athens Greece 2004; 18: 67–71.
25. Pan H, Cui B, Huang Y, Yang J, Ba-Thein W. Nasal carriage of common bacterial pathogens among healthy kindergarten children in Chaoshan region, southern China: a cross-sectional study. BMC Pediatr 2016; 16: 161.
26. Ko FWS, Ng TKC, Li TST, Fok JPC, Chan MCH, Wu AKL, et al. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong. Respir Med 2005; 99: 454–60.
27. Ko FWS, Lam RKY, Li TST, Fok JPC, Chan MCH, Ng TKC, et al. Sputum bacteriology in patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease and concomitant pneumonia in Hong Kong. Intern Med J 2005; 35: 661–7.
28. Mendes C, Marin ME, Quiñones F, Sifuentes-Osornio J, Siller CC, Castanheira M, et al. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000). Braz J Infect Dis Off Publ Braz Soc Infect Dis 2003; 7: 44–61.
29. Haque R, Akter ML, Salam MA. Prevalence and susceptibility of uropathogens: a recent report from a teaching hospital in Bangladesh. BMC Res Notes 2015; 8: 416.
30. Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect Dis 2013;13: 19.
31. Costa T, Linhares I, Ferreira R, Neves J, Almeida A. Frequency and Antibiotic Resistance of Bacteria Implicated in Community Urinary Tract Infections in North Aveiro Between 2011 and 2014. Microb Drug Resist Larchmt N 2018; 24: 493–504.
32. Lo DS, Rodrigues L, Koch VHK, Gilio AE. Clinical and laboratory features of urinary tract infections in young infants. J Bras Nefrol 2018; 40: 66-72.
33. Hamdan HZ, Kubbara E, Adam AM, Hassan OS, Suliman SO, Adam I. Urinary tract infections and antimicrobial sensitivity among diabetic patients at Khartoum, Sudan. Ann Clin Microbiol Antimicrob 2015; 14: 26.
34. Opilla M. Epidemiology of bloodstream infection associated with parenteral nutrition. Am J Infect Control 2008; 36: S173.e5-8.
35. Tang CQ, Li JQ, Shou BM, Pan BH, Chen TS, Xiao YQ, et al. Epidemiology and outcomes of bloodstream infections in 177 severe burn patients from an industrial disaster: a multicentre retrospective study. Clin Microbiol Infect 2018; 24: 199. e1-199.e7.
36. Ammann RA, Laws HJ, Schrey D, Ehlert K, Moser O, Dilloo D, et al. Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factors. Eur J Pediatr 2015; 174: 675–86.
37. Takeshita N, Kawamura I, Kurai H, Araoka H, Yoneyama A, Fujita T, et al. Unique characteristics of community-onset healthcare- associated bloodstream infections: a multi-centre prospective surveillance study of bloodstream infections in Japan. J Hosp Infect 2017; 96: 29–34.
38. Mitt P, Adamson V, Lõivukene K, Lang K, Telling K, Päro K, et al. Epidemiology of nosocomial bloodstream infections in Estonia. J Hosp Infect 2009; 71: 365–70.
2. Lizioli A, Privitera G, Alliata E, Antonietta Banfi EM, Boselli L, Panceri ML, et al. Prevalence of nosocomial infections in Italy: result from the Lombardy survey in 2000. J Hosp Infect 2003; 54: 141–8.
3. Pancharti P, Leksawas N, Sukamwang K, Tantisiriwat W, Danchaivijitr S. Impacts of nosocomial infection among elderly patients in Inburi Hospital. J Med Assoc Thai 2005; 88: S83-85.
4. Nosocomiale infecties in België, deel 2: impact op Mortaliteit en Kosten [Internet]. [cited May 18, 2018]. Available from: /en/node/792
5. Rosenthal VD, Maki DG, Jamulitrat S, Medeiros EA, Todi SK, Gomez DY, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary for 2003-2008, issued June 2009. Am J Infect Control 2010; 38: 95-104.e2.
6. Danchaivijitr S, Dhiraputra C, Santiprasitkul S, Judaeng T. Prevalence and impacts of nosocomial infection in Thailand 2001. J Med Assoc Thai 2005; 88: S1–9.
7. Danchaivijitr S, Judaeng T, Sripalakij S, Naksawas K, Plipat T. Prevalence of nosocomial infection in Thailand 2006. J-Med Assoc Thai 2007; 90: 1524.
8. Dejsirilert S, Suankratay C, Trakulsomboon S, Thongmali O, Sawanpanyalert P, Aswapokee N, et al. National Antimicrobial Resistance Surveillance, Thailand (NARST) data among clinical isolates of Pseudomonas aeruginosa in Thailand from 2000 to 2005. J Med Assoc Thai 2009; 92: S68-75.
9. Petdachai W. Ventilator-associated pneumonia in a newborn intensive care unit. Southeast Asian J Trop Med Public Health 2004; 35: 724–9.
10. Bayani M, Siadati S, Rajabnia R, Taher AA. Drug Resistance of Pseudomonas aeruginosa and Enterobacter cloacae Isolated from ICU, Babol, Northern Iran. Int J Mol Cell Med 2013; 2: 204–9.
11. Gurung J, Khyriem AB, Banik A, Lyngdoh WV, Choudhury B, Bhattacharyya P. Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit. Indian J Crit Care Med 2013; 17: 214–8.
12. Rhodes D, Cheng AC, McLellan S, Guerra P, Karanfilovska D, Aitchison S, et al. Reducing Staphylococcus aureus bloodstream infections associated with peripheral intravenous cannulae: successful implementation of a care bundle at a large Australian health service. J Hosp Infect 2016; 94: 86-91
13. Nuvials X, Palomar M, Alvarez-Lerma F, Olaechea P, Otero S, Uriona S, et al. Primary bacteriemia and catheter related bloodstream infection in patients admitted to ICU. risk factors associated with mortality. ENVIN-HELICS registry data. Intensive Care Med Exp 2015; 3: A889.
14. Sader HS, Castanheira M, Flamm RK, Mendes RE, Farrell DJ, Jones RN. Ceftazidime/avibactam tested against Gram-negative bacteria from intensive care unit (ICU) and non-ICU patients, including those with ventilator-associated pneumonia. Int J Antimicrob Agents 2015; 46: 53–9.
15. Tumbarello M, De Pascale G, Trecarichi EM, Spanu T, Antonicelli F, Maviglia R, et al. Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients. Intensive Care Med 2013; 39: 682–92.
16. Nathwani D, Raman G, Sulham K, Gavaghan M, Menon V. Clinical and economic consequences of hospital-acquired resistant and multidrug-resistant Pseudomonas aeruginosa infections: a systematic review and meta-analysis. Antimicrob Resist Infect Control 2014; 3: 32.
17. Djordjevi Z, Gajovi O, Mijailovi Z, Ili A, Stoli R. [Risk factors of nosocomial infections caused by piperacillin-tazobactam resistant Pseudomonas aeruginosa]. Srp Arh Celok Lek 2013; 141: 640–7.
18. Ryakitimbo A, Philemon R, Mazuguni F, Msuya L. Prevalence and antimicrobial sensitivity pattern of urinary tract infection among children with cerebral palsy, Moshi, Tanzania. Pediatr Health Med Ther 2018; 9: 59–65.
19. Anígilájé EA, Bitto TT. Prevalence and Predictors of Urinary Tract Infections among Children with Cerebral Palsy in Makurdi, Nigeria. Int J Nephrol 2013; 2013: 937268.
20. Lin S-H, Kuo P-H, Hsueh P-R, Yang P-C, Kuo S-H. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa. Respirol Carlton Vic 2007; 12: 81–7.
21. El-Sheikh SM, El-Assouli SM, Mohammed KA, Albar M. Bacteria and viruses that cause respiratory tract infections during the pilgrimage (Haj) season in Makkah, Saudi Arabia. Trop Med Int Health TM IH 1998; 3: 205–9.
22. Alamoudi OS. Bacterial infection and risk factors in outpatients with acute exacerbation of chronic obstructive pulmonary disease: a 2-year prospective study. Respirol Carlton Vic 2007; 12: 283–7.
23. Lewnard JA, Givon-Lavi N, Huppert A, Pettigrew MM, Regev-Yochay G, Dagan R, et al. Epidemiological Markers for Interactions Among Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Upper Respiratory Tract Carriage. J Infect Dis 2016 15;213:1596–605.
24. Numazaki K, Chiba S, Umetsu M, Tanaka T, Yoshimura H, Kuniya Y, et al. Etiological agents of lower respiratory tract infections in Japanese children. Vivo Athens Greece 2004; 18: 67–71.
25. Pan H, Cui B, Huang Y, Yang J, Ba-Thein W. Nasal carriage of common bacterial pathogens among healthy kindergarten children in Chaoshan region, southern China: a cross-sectional study. BMC Pediatr 2016; 16: 161.
26. Ko FWS, Ng TKC, Li TST, Fok JPC, Chan MCH, Wu AKL, et al. Sputum bacteriology in patients with acute exacerbations of COPD in Hong Kong. Respir Med 2005; 99: 454–60.
27. Ko FWS, Lam RKY, Li TST, Fok JPC, Chan MCH, Ng TKC, et al. Sputum bacteriology in patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease and concomitant pneumonia in Hong Kong. Intern Med J 2005; 35: 661–7.
28. Mendes C, Marin ME, Quiñones F, Sifuentes-Osornio J, Siller CC, Castanheira M, et al. Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Latin America: results from the PROTEKT surveillance study (1999-2000). Braz J Infect Dis Off Publ Braz Soc Infect Dis 2003; 7: 44–61.
29. Haque R, Akter ML, Salam MA. Prevalence and susceptibility of uropathogens: a recent report from a teaching hospital in Bangladesh. BMC Res Notes 2015; 8: 416.
30. Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect Dis 2013;13: 19.
31. Costa T, Linhares I, Ferreira R, Neves J, Almeida A. Frequency and Antibiotic Resistance of Bacteria Implicated in Community Urinary Tract Infections in North Aveiro Between 2011 and 2014. Microb Drug Resist Larchmt N 2018; 24: 493–504.
32. Lo DS, Rodrigues L, Koch VHK, Gilio AE. Clinical and laboratory features of urinary tract infections in young infants. J Bras Nefrol 2018; 40: 66-72.
33. Hamdan HZ, Kubbara E, Adam AM, Hassan OS, Suliman SO, Adam I. Urinary tract infections and antimicrobial sensitivity among diabetic patients at Khartoum, Sudan. Ann Clin Microbiol Antimicrob 2015; 14: 26.
34. Opilla M. Epidemiology of bloodstream infection associated with parenteral nutrition. Am J Infect Control 2008; 36: S173.e5-8.
35. Tang CQ, Li JQ, Shou BM, Pan BH, Chen TS, Xiao YQ, et al. Epidemiology and outcomes of bloodstream infections in 177 severe burn patients from an industrial disaster: a multicentre retrospective study. Clin Microbiol Infect 2018; 24: 199. e1-199.e7.
36. Ammann RA, Laws HJ, Schrey D, Ehlert K, Moser O, Dilloo D, et al. Bloodstream infection in paediatric cancer centres--leukaemia and relapsed malignancies are independent risk factors. Eur J Pediatr 2015; 174: 675–86.
37. Takeshita N, Kawamura I, Kurai H, Araoka H, Yoneyama A, Fujita T, et al. Unique characteristics of community-onset healthcare- associated bloodstream infections: a multi-centre prospective surveillance study of bloodstream infections in Japan. J Hosp Infect 2017; 96: 29–34.
38. Mitt P, Adamson V, Lõivukene K, Lang K, Telling K, Päro K, et al. Epidemiology of nosocomial bloodstream infections in Estonia. J Hosp Infect 2009; 71: 365–70.
ดาวน์โหลด
เผยแพร่แล้ว
2018-10-06
รูปแบบการอ้างอิง
1.
Putthanachote N, Munjit S, Prathumkhan N, Sangsa N, Phuangsriken S, Charoensaen J, PongKaew O, Gudwongsa W, Sarakran P, Treesorn K, Kucharin P. ความชุกของเชื้อแบคทีเรียฉวยโอกาสที่แยกได้จากสิ่งส่งตรวจของผู้ป่วยที่เข้ารับการรักษาในโรงพยาบาลร้อยเอ็ด ปี พ. ศ. 2560. SRIMEDJ [อินเทอร์เน็ต]. 6 ตุลาคาม 2018 [อ้างถึง 28 ธันวาคม 2025];33(6):358-65. available at: https://li01.tci-thaijo.org/index.php/SRIMEDJ/article/view/149328
ฉบับ
ประเภทบทความ
Original Articles
